Role of Th17 cells and interleukin 17 in graft-versushost disease and graft-versusleukemia reactivity - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 290

[27] Ma CS, Chew GY, Simpson N, Priyadarshi A, Wong M, Grimbacher B, et al. Deficiency of
Th17 cells in hyper IgE syndrome due to mutations in STAT3. J Exp Med 2008;205:1551-7.
[28] de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, et al. Muta-
tions in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells.
J Exp Med 2008;205:1543-50.
[29] Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, et al. IL-6 programs T H -17
cell differentiation by promoting sequential engagement of the IL-21 and IL-23 path-
ways. Nat Immunol 2007;8:967-74.
[30] Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, et al. Essential
autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature
2007;448:480-3.
[31] Korn T, Bettelli E, Gao W, Awasthi A, Jäger A, Strom TB, et al. IL-21 initiates an alterna-
tive pathway to induce proinflammatory TH17 cells. Nature 2007;448:484-7.
[32] Kidoya H, Umemura M, Kawabe T, Matsuzaki G, Yahagi A, Imamura R, et al. Fas ligand
induces cell-autonomous IL-23 production in dendritic cells, a mechanism for Fas
ligand-induced IL-17 production. J Immunol 2005;175:8024-31.
[33] Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1
in the induction of IL-17-producing T cells that mediate autoimmune encephalomyeli-
tis. J Exp Med 2006;203:1685-91.
[34] Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cyto-
kines in inflammation. Immunity 2008;28:454-67.
[35] Kuestner RE, Taft DW, Haran A, Brandt CS, Brender T, Lum K, et al. Identification of
the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F. J Immunol
2007;179:5462-73.
[36] Chang SH, Dong C. Signaling of interleukin-17 family cytokines in immunity and in-
flammation. Cell Signalling 2011;23:1069-75.
[37] O'Garra A. Cytokines induce the development of functionally heterogeneous T helper
cell subsets. Immunity 1998;8:275-83.
[38] Murphy KM, Reiner SL. The lineage decisions of helper T cells. Nat Rev Immunol
2002;2:933-44.
[39] Pène J, Chevalier S, Preisser L, Vénéreau E, Guilleux MH, Ghannam S, et al. Chronically
inflamed human tissues are infiltrated by highly differentiated T H 17 lymphocytes. J Im-
munol 2008;180:7423-30.
[40] Luger D, Silver PB, Tang J, Cua D, Chen Z, Iwakura Y, et al. Either a T H 17 or a T H 1 effec-
tor response can drive autoimmunity: conditions of disease induction affect dominant
effector category. J Exp Med 2008;205:799-810.
[41] Shi G, Cox CA, Vistica BP, Tan C, Wawrousek EF, Gery I. Phenotype switching by inflam-
mation-inducing polarized Th17 cells, but not by Th1 cells. J Immunol 2008;181:7205-13.
[42] Stritesky GL, Yeh N, Kaplan MH. IL-23 promotes maintenance but not commitment to
the T H 17 lineage. J Immunol 2008;181:5948-55.
[43] Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in im-
munological tolerance to self and non-self. Nat Immunol 2005;6:345-52.
[44] Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY. Regula-
tory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity
2005;22:329-41.
[45] Curotto de Lafaille MA, Lafaille JJ. Natural and adaptive Foxp3 + regulatory T cells: more
of the same or a division of labor? Immunity 2009;30:626-35.
[46] Faria AM, Weiner HL. Oral tolerance and TGF-beta-producing cells. Inflammation Al-
lergy Drug Targets 2006;5:179-90.
[47] Wan YY, Flavell RA. The roles for cytokines in the generation and maintenance of regu-
latory T cells. Immunol Rev 2006;212:114-30.
[48] Lu Y, Sakamaki S, Kuroda H, Kusakabe T, Konuma Y, Akiyama T, et al. Prevention of
lethal acute graft-versus-host disease in mice by oral administration of T helper 1
inhibitor, TAK-603. Blood 2001;97:1123-30.
[49] Krenger W, Ferrara JL. Graft-versus-host disease and the Th1/Th2 paradigm. Immunol
Res 1996;15:50-73.
[50] Fowler DH, Kurasawa K, Husebekk A, Cohen PA, Gress RE. Cells of Th2 cytokine pheno-
type prevent LPS-induced lethality during murine graft-versus-host reaction: regula-
tion of cytokines and CD8 + lymphoid engraftment. J Immunol 1994;152:1004-13.
[51] Fowler DH, Kurasawa K, Smith R, Eckhaus MA, Gress RE. Donor CD4-enriched cells of
Th2 cytokine phenotype regulate graft-versus-host disease without impairing alloge-
neic engraftment in sublethally irradiated mice. Blood 1994;84:3540-9.
[52] Krenger W, Snyder KM, Byon JC, Falzarano G, Ferrara JL. Polarized type 2 alloreac-
tive CD4 + and CD8 + donor T cells fail to induce experimental acute graft-versus-host
disease. J Immunol 1995;155:585-93.

293